Researchers have demonstrated how quantum computing combined with artificial intelligence could accelerate the development of drugs for underserved populations and rare diseases, according to WIRED. The scientists worked on the project by cobbling together funding and time as a side endeavor alongside their primary research responsibilities.
The team focused on using these advanced technologies to generate new peptides, which are short chains of amino acids that can serve as the building blocks for potential therapeutic drugs. According to the WIRED report, the research represents an effort to address medical needs that often receive less attention from major pharmaceutical companies due to smaller market opportunities.
The project highlights how emerging quantum computing capabilities, when paired with AI systems, could potentially transform the drug discovery process. By taking on this work as a side project, the researchers were able to explore applications of quantum computing in pharmaceutical development despite limited dedicated resources for such experimental approaches.